 CAMBRIDGE, Mass., Sept. 07, 2021 GLOBE NEWSWIRE -- Spero Therapeutics, Inc. Nasdaq: SPRO, a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in high unmet need areas involving multi-drug resistant bacterial infections and rare diseases, today announced that Ankit Mahadevia, M.D., President and Chief Executive Officer of Spero Therapeutics, will present and be available for virtual one-on-one meetings at the H.C. Wainwright 23rd Annual Global Investment Conference, the Oppenheimer Fall Healthcare Life Sciences MedTech Summit, and the 2021 Cantor Virtual Global Healthcare Conference, taking place virtually September 13 15th, 2021, September 20 23rd, 2021, and September 27 30th, 2021, respectively. 